Allarity Therapeutics ALLR
NASDAQ ALLR
$0.97 +0.01 (+0.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Net Margin (2026)

Updated

Allarity Therapeutics' Net Margin was -11000.00% in Q1 2026.

Analysis

Allarity Therapeutics (ALLR) Net Margin (2026) Analysis & Trends

For FY2025, Net Margin at Allarity Therapeutics came in at -3509.69%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Allarity Therapeutics 1.56 Mn 1.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,000.00%
API Access

Allarity Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY